InforMax Licenses GenoMax to Abgenix | GenomeWeb

NEW YORK, May 10 -  InforMax has licensed its GenoMax bioinformatics software to Abgenix, the company said Thursday.

The licensing agreement, which occurred during the first quarter, comprises one of 32 sales to pharmaceutical, biotechnology, and academic customers, according to InforMax CEO Alex Titomirov.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."